152 related articles for article (PubMed ID: 15083745)
1. Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature.
Gieffers J; van Zandbergen G; Rupp J; Sayk F; Krüger S; Ehlers S; Solbach W; Maass M
Eur Respir J; 2004 Apr; 23(4):506-10. PubMed ID: 15083745
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia pneumoniae: crossing the barriers?
Blasi F; Centanni S; Allegra L
Eur Respir J; 2004 Apr; 23(4):499-500. PubMed ID: 15083742
[No Abstract] [Full Text] [Related]
3. Chlamydia pneumoniae hides inside apoptotic neutrophils to silently infect and propagate in macrophages.
Rupp J; Pfleiderer L; Jugert C; Moeller S; Klinger M; Dalhoff K; Solbach W; Stenger S; Laskay T; van Zandbergen G
PLoS One; 2009 Jun; 4(6):e6020. PubMed ID: 19547701
[TBL] [Abstract][Full Text] [Related]
4. Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection.
Rupp J; Droemann D; Goldmann T; Zabel P; Solbach W; Vollmer E; Branscheid D; Dalhoff K; Maass M
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):197-203. PubMed ID: 15196568
[TBL] [Abstract][Full Text] [Related]
5. A platform for studying the transfer of Chlamydia pneumoniae infection between respiratory epithelium and phagocytes.
Kortesoja M; Trofin RE; Hanski L
J Microbiol Methods; 2020 Apr; 171():105857. PubMed ID: 32006529
[TBL] [Abstract][Full Text] [Related]
6. Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen.
Wizel B; Starcher BC; Samten B; Chroneos Z; Barnes PF; Dzuris J; Higashimoto Y; Appella E; Sette A
J Immunol; 2002 Sep; 169(5):2524-35. PubMed ID: 12193722
[TBL] [Abstract][Full Text] [Related]
7. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse.
Moazed TC; Kuo CC; Grayston JT; Campbell LA
J Infect Dis; 1998 May; 177(5):1322-5. PubMed ID: 9593019
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E-deficient mice develop an anti-Chlamydophila pneumoniae T helper 2 response and resist vascular infection.
Nazzal D; Therville N; Yacoub-Youssef H; Garcia V; Thomsen M; Levade T; Segui B; Benoist H
J Infect Dis; 2010 Sep; 202(5):782-90. PubMed ID: 20632890
[TBL] [Abstract][Full Text] [Related]
9. Experimental rabbit models of Chlamydia pneumoniae infection.
Moazed TC; Kuo C; Patton DL; Grayston JT; Campbell LA
Am J Pathol; 1996 Feb; 148(2):667-76. PubMed ID: 8579129
[TBL] [Abstract][Full Text] [Related]
10. Could past Chlamydial vascular infection promote the dissemination of Chlamydia pneumoniae to the brain?
Di Pietro M; Filardo S; Cazzavillan S; Segala C; Bevilacqua P; Bonoldi E; D'Amore ES; Rassu M; Sessa R
J Biol Regul Homeost Agents; 2013; 27(1):155-64. PubMed ID: 23489695
[TBL] [Abstract][Full Text] [Related]
11. The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanism.
He X; Berland R; Mekasha S; Christensen TG; Alroy J; Kramnik I; Ingalls RR
PLoS Pathog; 2013; 9(8):e1003569. PubMed ID: 24009502
[TBL] [Abstract][Full Text] [Related]
12. Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae.
Maass M; Gieffers J; Solbach W
Herz; 2000 Mar; 25(2):68-72. PubMed ID: 10829241
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells.
MacIntyre A; Abramov R; Hammond CJ; Hudson AP; Arking EJ; Little CS; Appelt DM; Balin BJ
J Neurosci Res; 2003 Mar; 71(5):740-50. PubMed ID: 12584732
[TBL] [Abstract][Full Text] [Related]
14. Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria.
Shima K; Coopmeiners J; Graspeuntner S; Dalhoff K; Rupp J
FEBS Lett; 2016 Nov; 590(21):3887-3904. PubMed ID: 27509029
[TBL] [Abstract][Full Text] [Related]
15. Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model.
Erkkilä L; Saario E; Laitinen K; Saikku P; Leinonen M
Vaccine; 2008 May; 26(20):2503-9. PubMed ID: 18433949
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods.
Meijer A; Roholl PJ; Gielis-Proper SK; Meulenberg YF; Ossewaarde JM
J Clin Pathol; 2000 Dec; 53(12):904-10. PubMed ID: 11265174
[TBL] [Abstract][Full Text] [Related]
17. Mast cells play an important role in chlamydia pneumoniae lung infection by facilitating immune cell recruitment into the airway.
Chiba N; Shimada K; Chen S; Jones HD; Alsabeh R; Slepenkin AV; Peterson E; Crother TR; Arditi M
J Immunol; 2015 Apr; 194(8):3840-51. PubMed ID: 25754739
[TBL] [Abstract][Full Text] [Related]
18. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice.
Yang ZP; Kuo CC; Grayston JT
J Infect Dis; 1995 Mar; 171(3):736-8. PubMed ID: 7876631
[TBL] [Abstract][Full Text] [Related]
19. Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue.
Erkkilä L; Laitinen K; Laurila A; Saikku P; Leinonen M
Vaccine; 2002 May; 20(17-18):2318-24. PubMed ID: 12009287
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
Caligiuri G; Rottenberg M; Nicoletti A; Wigzell H; Hansson GK
Circulation; 2001 Jun; 103(23):2834-8. PubMed ID: 11401941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
